お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
市場調査レポート
商品コード
872608

脳震盪の世界市場:将来展望

Global Concussions Market Research Report Forecast to 2023

出版日: | 発行: Market Research Future | ページ情報: 英文 118 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.77円
脳震盪の世界市場:将来展望
出版日: 2019年05月31日
発行: Market Research Future
ページ情報: 英文 118 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の脳震盪診断・治療の関連市場について分析し、疾患の概要や市場の基本構造、主な市場促進・抑制要因、全体的な市場動向の見通し (過去4年間・今後5年間分)、診断/治療段階別・エンドユーザー別・地域別の詳細動向、市場シェア構造、主要企業のプロファイル・業績・戦略などを調査しております。

第1章 エグゼクティブ・サマリー

第2章 分析概略

第3章 分析手法

第4章 市場のダイナミクス

  • 概要
  • 市場促進要因
  • 市場抑制要因
  • 市場機会

第5章 市場要因の分析

  • バリューチェーン分析
    • 研究開発 (R&D)
    • 製造
    • 流通・販売
    • アフターサービス/モニタリング
  • ポーターのファイブフォース分析
  • 投資企画
  • 価格動向分析

第6章 世界の脳震盪市場:診断・治療段階別

  • 概況
  • 診断方法
  • 治療方法

第7章 世界の脳震盪市場:エンドユーザー別

  • 概要
  • 病院・診療所
  • 診断センター
  • 支払者

第8章 世界の脳震盪市場:地域別

  • 概要
  • 南北アメリカ
    • 北米 (米国、カナダ)
    • ラテンアメリカ
  • 欧州
    • 西欧 (ドイツ、フランス、英国、イタリア、スペインなど)
    • 東欧
  • アジア太平洋地域 (中国、日本、インド、オーストラリア、韓国など)
  • 中東・アフリカ

第9章 競争環境

  • 競争シナリオ
  • 脳震盪治療業界における代表的な企業
  • 脳震盪治療業界における代表的な企業
  • 主な結論

第10章 企業プロファイル

  • Teva Pharmaceutical Industries Ltd
    • 企業概要
    • 主な財務指標
    • 主要製品/サービス
    • 近年の主な動向
    • SWOT分析
    • 主要戦略
  • Integra LifeSciences Corporation
  • Medtronic Plc
  • Sun Pharmaceutical Industries Ltd
  • Lupin
  • Zydus Cadila
  • Pfizer, Inc.
  • Mylan N.V.
  • Novartis AG
  • Sanofi S. A.

第11章 結論

  • 主な分析結果
図表

List of Tables

  • TABLE 1 GLOBAL CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 2 GLOBAL CONCUSSIONS MARKET FOR DIAGNOSIS, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 3 GLOBAL CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 4 GLOBAL CONCUSSIONS MARKET FOR TREATMENT, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 5 GLOBAL CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 6 GLOBAL CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 7 GLOBAL CONCUSSIONS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 8 GLOBAL CONCUSSIONS MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 9 GLOBAL CONCUSSIONS MARKET FOR PAYERS, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 10 GLOBAL CONCUSSIONS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 11 AMERICAS: CONCUSSIONS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 12 AMERICAS: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 13 AMERICAS: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 14 AMERICAS: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 15 AMERICAS: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 16 NORTH AMERICA: CONCUSSIONS MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 17 NORTH AMERICA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 18 NORTH AMERICA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 19 NORTH AMERICA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 20 NORTH AMERICA: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 21 US: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 22 US: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 23 US: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 24 US: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 25 CANADA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 26 CANADA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 27 CANADA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 28 CANADA: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 29 LATIN AMERICA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 30 LATIN AMERICA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 31 LATIN AMERICA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 32 LATIN AMERICA: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 33 EUROPE: CONCUSSIONS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 34 EUROPE: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 35 EUROPE: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 36 EUROPE: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 37 EUROPE: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 38 WESTERN EUROPE: CONCUSSIONS MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 39 WESTERN EUROPE: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 40 WESTERN EUROPE: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 41 WESTERN EUROPE: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 42 WESTERN EUROPE: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 43 GERMANY: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 44 GERMANY: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 45 GERMANY: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 46 GERMANY: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 47 FRANCE: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 48 FRANCE: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 49 FRANCE: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 50 FRANCE: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 51 UK: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 52 UK: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 53 UK: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 54 UK: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 55 ITALY: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 56 ITALY: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 57 ITALY: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 58 ITALY: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 59 SPAIN: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 60 SPAIN: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 61 SPAIN: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 62 SPAIN: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 63 REST OF WESTERN EUROPE: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 64 REST OF WESTERN EUROPE: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 65 REST OF WESTERN EUROPE: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 66 REST OF WESTERN EUROPE: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 67 EASTERN EUROPE: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 68 EASTERN EUROPE: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 69 EASTERN EUROPE: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 70 EASTERN EUROPE: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 71 ASIA-PACIFIC: CONCUSSIONS MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 72 ASIA-PACIFIC: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 73 ASIA-PACIFIC: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 74 ASIA-PACIFIC: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 75 ASIA-PACIFIC: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 76 CHINA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 77 CHINA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 78 CHINA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 79 CHINA: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 80 JAPAN: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 81 JAPAN: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 82 JAPAN: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 83 JAPAN: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 84 INDIA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 85 INDIA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 86 INDIA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 87 INDIA: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 88 AUSTRALIA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 89 AUSTRALIA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 90 AUSTRALIA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 91 AUSTRALIA: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 92 SOUTH KOREA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 93 SOUTH KOREA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 94 SOUTH KOREA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 95 SOUTH KOREA: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 96 REST OF ASIA-PACIFIC: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 97 REST OF ASIA-PACIFIC: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 98 REST OF ASIA-PACIFIC: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 99 REST OF ASIA-PACIFIC: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 100 MIDDLE EAST & AFRICA: CONCUSSIONS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 101 MIDDLE EAST & AFRICA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 102 MIDDLE EAST & AFRICA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 103 MIDDLE EAST & AFRICA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 104 MIDDLE EAST & AFRICA: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 105 MIDDLE EAST: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 106 MIDDLE EAST: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 107 MIDDLE EAST: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 108 MIDDLE EAST: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 109 AFRICA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 110 AFRICA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 111 AFRICA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 112 AFRICA: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 113 MAJOR PLAYERS IN THE CONCUSSION DIAGNOSTIC MARKET
  • TABLE 114 GLOBAL CONCUSSION MARKET: KEY DEVELOPMENT

List of Figures

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL CONCUSSIONS MARKET
  • FIGURE 3 GLOBAL CONCUSSIONS MARKET SHARE, BY DIAGNOSIS AND TREATMENT, 2017 (%)
  • FIGURE 4 GLOBAL CONCUSSIONS MARKET BY DIAGNOSIS AND TREATMENT, 2016-2023 (USD MILLION)
  • FIGURE 5 GLOBAL CONCUSSIONS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • FIGURE 6 GLOBAL CONCUSSIONS MARKET BY END USER, 2016-2023 (USD MILLION)
  • FIGURE 7 GLOBAL CONCUSSIONS MARKET: MARKET STRUCTURE
  • FIGURE 8 RESEARCH PROCESS OF MRFR
  • FIGURE 9 TOP-DOWN & BOTTOM-UP APPROACH
  • FIGURE 10 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CONCUSSIONS MARKET
  • FIGURE 11 VALUE CHAIN: GLOBAL CONCUSSIONS MARKET
  • FIGURE 12 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CONCUSSIONS MARKET
  • FIGURE 13 GLOBAL CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2017 (%)
  • FIGURE 14 GLOBAL CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2017 AND 2023 (USD MILLION)
  • FIGURE 15 GLOBAL CONCUSSIONS MARKET, BY END USER, 2017 (%)
  • FIGURE 16 GLOBAL CONCUSSIONS MARKET, BY END USER, 2017 AND 2023 (USD MILLION)
  • FIGURE 17 GLOBAL CONCUSSIONS MARKET, BY REGION, 2017 (%)
  • FIGURE 18 GLOBAL CONCUSSIONS MARKET, BY REGION, 2017 AND 2023 (USD MILLION)
  • FIGURE 19 AMERICAS: CONCUSSIONS MARKET, BY REGION, 2017 AND 2023
  • FIGURE 20 NORTH AMERICA: CONCUSSIONS MARKET, BY COUNTRY, 2017 AND 2023
  • FIGURE 21 EUROPE: CONCUSSIONS MARKET, BY REGION, 2017 AND 2023
  • FIGURE 22 WESTERN EUROPE: CONCUSSIONS MARKET, BY COUNTRY, 2017 AND 2023
  • FIGURE 23 ASIA-PACIFIC: CONCUSSIONS MARKET, BY COUNTRY, 2017 AND 2023
  • FIGURE 24 MIDDLE EAST & AFRICA: CONCUSSIONS MARKET, BY REGION, 2017 AND 2023
  • FIGURE 25 MAJOR PLAYERS IN CONCUSSION THERAPEUTICS MARKET
  • FIGURE 26 GLOBAL CONCUSSION MARKET, COMPETITIVE LANDSCAPE (%)
目次

Global Concussions Market Information: by Diagnosis & Treatment (Diagnosis, Treatment), End User (Hospitals and Clinics, Diagnostic Centers, Payers, Others), and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2023

Market analysis

Head wounds that are extreme enough to influence cerebrum capacities are named as traumatic brain injuries (TBI). A blackout or concussion is a type of mellow traumatic head wounds. Rising instances of concussion combined with the developing item improvement for the administration of concussion by a few organizations have prompted the development of the global concussions market as of late. Furthermore, the developing geriatric populace is likewise expected to fuel the development of the market. In any case, the absence of a prepared workforce in various creating and immature economies is probably going to hamper the market development over the estimated time frame. As indicated by a paper distributed by the National Center for Biotechnology Information (NCBI) in March 2015, roughly 42 million individuals all inclusive endure mild traumatic brain injury (MTBI) or concussion consistently. Consequently, the expanding rate of concussions is relied upon to give ideal foundations to the market to develop over the figure time frame. The Global Concussions Market is projected to register a growth rate of CAGR 3.22% to reach the value of USD 1,060.4 million until the year 2023.

Market segmentation

The global concussions market is segmented on the basis of its Diagnosis & Treatment, end-user, and regional demand. On the basis of its Diagnosis & Treatment, the global concussions market is bifurcated as Treatment and Diagnosis. Based on its end-user, the global concussions market is divided into Diagnostic Centers, Hospitals and Clinics, Payers, Others.

Regional analysis

Geographically, the global concussions market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Sun Pharmaceutical Industries Ltd, Medtronic Plc, Integra LifeSciences Corporation, and Teva Pharmaceutical Industries Ltd., Sanofi S.A., Novartis AG, Mylan N.V., Pfizer, Inc., Zydus Cadila, Lupin, among others are some of the major players in the global concussions market.

Table of Contents

1 Executive Summary

2 Market Introduction

  • 2.1 Definition
  • 2.2 Scope of the Study
  • 2.3 Market Structure

3 Research Methodology

  • 3.1 Research Process
  • 3.2 Primary Research
  • 3.3 Secondary Research
  • 3.4 Market Size Estimation
  • 3.5 Forecast Model

4 Market Dynamics

  • 4.1 Overview
  • 4.2 Drivers
    • 4.2.1 Increasing Incidence of Mild Traumatic Brain Injuries
    • 4.2.2 Ongoing Product Development and Approval
    • 4.2.3 Growing Geriatric Population
  • 4.3 Restraints
    • 4.3.1 Stringent Regulatory Framework
    • 4.3.2 Shortage of Trained Professionals
  • 4.4 Opportunities
    • 4.4.1 Growing Awareness about Concussions

5 Market Factor Analysis

    • 5.1.1 R&D and Designing
    • 5.1.2 Manufacturing
    • 5.1.3 Distribution & Sales
    • 5.1.4 Post-Sales Services
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Buyers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitutes
    • 5.2.5 Intensity of Rivalry
  • 5.3 Investment Opportunities
  • 5.4 Pricing Analysis

6 Global Concussions Market by Diagnosis & Treatment

  • 6.1 Overview
  • 6.2 Diagnosis
  • 6.3 Treatment

7 Global Concussions Market, by End User

  • 7.1 Overview
  • 7.2 Hospitals and Clinics
  • 7.3 Diagnostic Centers
  • 7.4 Payers

8 Global Concussions Market, by Region

  • 8.1 Overview
  • 8.2 Americas
    • 8.2.1 North America
      • 8.2.1.1 US
      • 8.2.1.2 Canada
    • 8.2.2 Latin America
  • 8.3 Europe
    • 8.3.1 Western Europe
      • 8.3.1.1 Germany
      • 8.3.1.2 France
      • 8.3.1.3 UK
      • 8.3.1.4 Italy
      • 8.3.1.5 Spain
      • 8.3.1.6 Rest of Western Europe
    • 8.3.2 Eastern Europe
  • 8.4 Asia-Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia-Pacific
  • 8.5 Middle East & Africa
    • 8.5.1 Middle East
    • 8.5.2 Africa

9 Competitive Landscape

  • 9.1 Competitive Scenario
  • 9.2 Prominent Players in the Concussion Therapeutics Industry
  • 9.3 Prominent Players in the Concussion Diagnostic Industry
  • 9.4 Key Developments

10 Company Profile

  • 10.1 Teva Pharmaceutical Industries Ltd
    • 10.1.1 Company Overview
    • 10.1.2 Financial Overview
    • 10.1.3 Products/Services Offered
    • 10.1.4 Key Developments
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Strategies
  • 10.2 Integra LifeSciences Corporation
    • 10.2.1 Company Overview
    • 10.2.2 Financial Overview
    • 10.2.3 Products Offering
    • 10.2.4 Key Developments
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Strategies
  • 10.3 Medtronic Plc
    • 10.3.1 Company Overview
    • 10.3.2 Financial Overview
    • 10.3.3 Products Offering
    • 10.3.4 Key Developments
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Strategies
  • 10.4 Sun Pharmaceutical Industries Ltd
    • 10.4.1 Company Overview
    • 10.4.2 Financial Overview
    • 10.4.3 Products/Services Offered
    • 10.4.4 Key Developments
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Strategies
  • 10.5 Lupin
    • 10.5.1 Company Overview
    • 10.5.2 Financial Overview
    • 10.5.3 Products/Services Offered
    • 10.5.4 Key Developments
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Strategies
  • 10.6 Zydus Cadila
    • 10.6.1 Company Overview
    • 10.6.2 Financial Overview
    • 10.6.3 Products/Services Offered
    • 10.6.4 Key Developments
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Strategies
  • 10.7 Pfizer, Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Financial Overview
    • 10.7.3 Products/Services Offered
    • 10.7.4 Key Developments
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Strategies
  • 10.8 Mylan N.V.
    • 10.8.1 Company Overview
    • 10.8.2 Financial Overview
    • 10.8.3 Products/Services Offered
    • 10.8.4 Key Developments
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Strategies
  • 10.9 Novartis AG
    • 10.9.1 Company Overview
    • 10.9.2 Financial Overview
    • 10.9.3 Products/Services Offered
    • 10.9.4 Key Developments
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Strategies
  • 10.1 Sanofi S. A.
    • 10.10.1 Company Overview
    • 10.10.2 Financial Overview
    • 10.10.3 Products/Services Offered
    • 10.10.4 Key Developments
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Strategies

11 Appendix

  • 11.1 References
  • 11.2 Related Reports
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.